Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LEPROT - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
EIF4A3 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
WBP4 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
STAM2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
PSMA3 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
RAB7A - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
DBI - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
APEX1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SLC33A1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
RP2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
B4GALT4 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
NBN - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SMARCAD1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
FAM76A - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ATF6 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SCP2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
PCBP2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SLC30A5 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
WDR11 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on